Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Prime Medicine, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Investor presentation, Quarterly results
Docs: "Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates",
"Prime Medicine August 2023"
07/26/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2023 4 Cahill Thomas (Director) has filed a Form 4 on Prime Medicine, Inc.
Txns: Granted 39,062 options to buy @ $14.83, valued at $579.3k
06/16/2023 4 Schenkein David P (Director) has filed a Form 4 on Prime Medicine, Inc.
Txns: Granted 39,062 options to buy @ $14.83, valued at $579.3k
06/16/2023 4 Foster-Cheek Kaye I (Director) has filed a Form 4 on Prime Medicine, Inc.
Txns: Granted 39,062 options to buy @ $14.83, valued at $579.3k
06/16/2023 4 NELSEN ROBERT (10% Owner) has filed a Form 4 on Prime Medicine, Inc.
Txns: Granted 39,062 options to buy @ $14.83, valued at $579.3k
06/16/2023 4 Kelly Michael Aaron (Director) has filed a Form 4 on Prime Medicine, Inc.
Txns: Granted 39,062 options to buy @ $14.83, valued at $579.3k
06/16/2023 4 Chung Wendy (Director) has filed a Form 4 on Prime Medicine, Inc.
Txns: Granted 39,062 options to buy @ $14.83, valued at $579.3k
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/12/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 4 GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.
Txns: Disposed of 15,000 shares @ $0
Sold 15,000 shares @ $16.9247, valued at $253.9k
Disposed of 5,000 shares @ $0
Sold 5,000 shares @ $15.7373, valued at $78.7k
06/07/2023 4 GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.
Txns: Disposed of 22,434 shares @ $0
Sold 22,434 shares @ $16.6984, valued at $374.6k
Disposed of 29,975 shares @ $0
Sold 29,975 shares @ $17.0197, valued at $510.2k
06/05/2023 144 Form 144 - Report of proposed sale of securities:
05/31/2023 4 GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.
Txns: Disposed of 12,602 shares @ $0
Sold 12,602 shares @ $13.6965, valued at $172.6k
Disposed of 16,805 shares @ $0
Sold 16,805 shares @ $13.7007, valued at $230.2k
05/30/2023 144 Form 144 - Report of proposed sale of securities:
05/26/2023 4 GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.
Txns: Disposed of 7,900 shares @ $0
Sold 7,900 shares @ $13.6608, valued at $107.9k
Disposed of 23,161 shares @ $0
Sold 23,161 shares @ $13.3834, valued at $310k
05/24/2023 4 GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.
Txns: Disposed of 87,922 shares @ $0
Sold 87,922 shares @ $14.1272, valued at $1.2M
Disposed of 43,939 shares @ $0
Sold 43,939 shares @ $14.7397, valued at $647.6k
05/18/2023 144 Form 144 - Report of proposed sale of securities:
05/18/2023 4 GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.
Txns: Sold 50,649 shares @ $12.5901, valued at $637.7k
Sold 15,000 shares @ $12.7733, valued at $191.6k
05/17/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting Data demonstrated Prime Editors efficiently, reproducibly and durably corrected the causative mutation of CGD, supporting advancement of development candidate PM359"
05/16/2023 4 GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.
Txns: Sold 27,290 shares @ $12.7234, valued at $347.2k
Sold 157,952 shares @ $12.7386, valued at $2M
05/12/2023 4 Marrazzo Jeffrey D (Director) has filed a Form 4 on Prime Medicine, Inc.
Txns: Granted 92,000 options to buy @ $14.04, valued at $1.3M
05/12/2023 3 Marrazzo Jeffrey D (Director) has filed a Form 3 on Prime Medicine, Inc.
05/12/2023 4 GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.
Txns: Sold 87,397 shares @ $14.0257, valued at $1.2M
Sold 21,819 shares @ $12.9815, valued at $283.2k
Sold 4,807 shares @ $13.7903, valued at $66.3k
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/11/2023 8-K Appointed a new director
05/11/2023 8-K Quarterly results
Docs: "Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates"
05/10/2023 4 GV 2019 GP, L.L.C. (10% Owner) has filed a Form 4 on Prime Medicine, Inc.
Txns: Sold 100,772 shares @ $14.1282, valued at $1.4M
Sold 321,238 shares @ $14.0787, valued at $4.5M
05/08/2023 144 Form 144 - Report of proposed sale of securities:
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy